跳至主要内容
临床试验/EUCTR2005-002833-10-AT
EUCTR2005-002833-10-AT进行中(未招募)不适用

Curative and palliative treatment of adults aged > 60 years with AML.A randomised trial by OSHO on the role of (1) early intensification {OSHO protocol} vs. common standard arm of German AML Intergroup Study, (2) allografting as consolidative immunotherapy vs. a second consolidation course in elderly patients,(3) prospective evaluation of the decision between curative and palliative treatment-intention. - AML 2004 OSHO #069

German Competence network Acute and Chronic Leukemias” sponsored by Federal Ministry of Education a0 个研究点目标入组 330 人开始时间: 2006年1月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
330

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • AML according to the WHO classification (1999)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years)
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Acute promyelocytic leukemie (APL; t(15;17))

研究者

发起方
German Competence network Acute and Chronic Leukemias” sponsored by Federal Ministry of Education a

相似试验